Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-23

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate respiratory parameters and functional capacity in coronary artery patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mortality Predictors in Coronary Care in Turkey

NCT05296694

Death, Cardiac

COMPLETED

Predictors of Heart Failure After ST-segment Elevation Myocardial Infarction (HF-EXPRESS)

NCT02650934

Heart Failure and ST Elevation Myocardial Infarction

UNKNOWN

Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction

NCT02649400

Heart Failure, Diastolic Coronary Artery Disease Inflammation

UNKNOWN

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

NCT07268859

Acute Coronary Syndromes Ticagrelor Dyspnea

RECRUITING NA

The Assessment of Survival After In-hospital Cardiac Arrest for 2 Years in Tertiary Hospital

NCT03484559

Cardiac Arrest

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Decreased pulmonary function as measured by forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), or peak expiratory flow (PEF) has been associated with an increased risk of cardiovascular mortality and morbidity. A low MIP value may generally indicate weak muscle strength and therefore be an indicator of general poor health. Respiratory muscle weakness and decreased respiratory muscle endurance affect exercise tolerance in individuals with chronic disease, including cardiovascular disease. Studies have supported the association of grip strength with frailty, physical activity, diabetes, functional limitation, nutritional status, metabolic syndrome, and mortality.

The study will evaluate respiratory parameters and functional capacity in coronary artery patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Individuals without cardiac and pulmonary disease

No interventions assigned to this group

Study Group

Individuals with coronary artery disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with coronary artery disease
* Volunteering to participate in the research

Exclusion Criteria

* Having a musculoskeletal problem
* Having unstable cardiac disease
* Having chronic heart failure (NYHA III-IV)
* A history of acute coronary syndrome or surgical revascularization less than 3 months ago
* Having arrhythmia
* Having the last stage of kidney disease
* Having active myocarditis or pericarditis

Minimum Eligible Age

41 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes